MASI.NASDAQMasimo CORP

Form 4: Masimo Executive Reports RSU Conversion Post-Merger

Sentiment:

Statement of Changes in Beneficial Ownership


Charles Dadswell, EVP and General Counsel of Masimo, reports the conversion of restricted stock units following the company's acquisition by Danaher Corporation.

Summary

  • Charles Dadswell, EVP and General Counsel of Masimo Corporation, filed a Form 4 regarding the disposition of restricted stock units (RSUs).
  • The transaction occurred on June 10, 2026, following the completion of the merger between Masimo Corporation and Danaher Corporation.
  • A total of 11,886 RSUs from an October 2025 grant and 10,261 RSUs from a March 2026 grant were disposed of as part of the merger conversion process.
  • These RSUs were converted into Danaher Corporation RSUs based on a merger consideration of $180.00 per share.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral administrative filing confirming the completion of a previously announced merger.

Positives

  • The merger successfully closed, providing liquidity and a defined exit value of $180.00 per share for equity holders.

Negatives

  • The reporting person no longer holds direct equity in Masimo Corporation as it is now a wholly owned subsidiary of Danaher Corporation.

Risks

  • Integration risks associated with the transition of Masimo into a subsidiary of Danaher Corporation.

Future Outlook

Masimo is now a wholly owned subsidiary of Danaher Corporation; future performance will be integrated into Danaher's consolidated financial reporting.

Management Comments

  • The transaction was executed pursuant to the Agreement and Plan of Merger dated February 16, 2026.

Industry Context

StockSavvy.ai notes that this filing confirms the finalization of a significant M&A event in the medical technology sector, reflecting ongoing consolidation trends where larger conglomerates like Danaher acquire specialized monitoring and healthcare technology firms.

Comparison to Industry Standards

  • The $180.00 per share acquisition price represents a standard premium-based exit for shareholders in the medical device sector.
  • The conversion of unvested equity into parent company equity is a standard practice in large-scale corporate acquisitions to ensure management retention during the integration phase.

Corporate Governance

Change TypeDescriptionEffective DateImpact Assessment
Change in ControlMasimo Corporation became a wholly owned subsidiary of Danaher Corporation.2026-06-10Significant change in corporate structure and governance oversight.

Stakeholder Impact

  • Shareholders have received the merger consideration.
  • Employees and executives are transitioning to the parent company's compensation structure.

Next Steps

  • Integration of Masimo operations into Danaher Corporation structure.

Key Dates

DateDescription
2025-10-22Original grant date of the first batch of restricted stock units.
2026-02-16Date of the Agreement and Plan of Merger.
2026-03-06Original grant date of the second batch of restricted stock units.
2026-06-10Effective date of the merger and transaction date for RSU conversion.
2026-06-12Date of filing for the Form 4.

Keywords

Masimo, Danaher, Merger, Form 4, RSU, Acquisition, Executive Compensation

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.